Data on sprytne.com is aggregated from official U.S. Government sources including the SEC EDGAR database, USAspending.gov, USPTO, and U.S. Census Bureau. In accordance with 17 U.S.C. § 105, works of the U.S. Government are not subject to copyright protection and reside in the Public Domain. sprytne.com provides value-added visualization and algorithmic analysis of these public records.
Not financial advice. sprytne.com is an automated market intelligence platform. We are not a registered investment advisor, broker, or dealer. Financial metrics, risk scores, and federal award data are for informational purposes only. Past performance (including government contract history) is not indicative of future market results. Verify all data via official SEC.gov filings.
This platform adheres to CCPA/GDPR standards regarding professional and public business data. Information displayed pertains to commercial entities and public officers in their professional capacity. For data verification or removal requests regarding non-public information, please visit our Contact page. Operated under Brand House Data Systems framework.
© 2026 sprytne.com — Institutional Data Intelligence — Federal Transparency Initiative
Financial benchmark analysis for 151 SEC-registered companies.
Sector Intelligence · Sprytne.com
The Surgical & Medical Instruments & Apparatus sector (SIC 3841) is led by Medline Inc. with $28.43B in annual revenue. Meanwhile, Orchestra BioMed Holdings, Inc. leads in growth at +1169.2% YoY. The most profitable player is 3M CO with $3.25B net income.
Based on the latest SEC EDGAR 10-K annual filings · Verified public data
| Rank | Company | Revenue | Details |
|---|---|---|---|
| #1 | Medline Inc.MDLN | $28.43B | YoY: +11.5% |
| #2 | 3M COMMM | $24.95B | YoY: +1.5% |
| #3 | BECTON DICKINSON & COBDX | $21.84B | YoY: +8.2% |
| #4 | BOSTON SCIENTIFIC CORPBSX | $20.07B | YoY: +19.9% |
| #5 | BAXTER INTERNATIONAL INCBAX | $11.24B | YoY: +5.7% |
| #6 | Solventum CorpSOLV | $8.32B | YoY: +0.9% |
| #7 | STRYKER CORPSYK | $5.87B | YoY: +11.9% |
| #8 | RESMED INCRMD | $5.15B | YoY: +9.8% |
| #9 | DEXCOM INCDXCM | $4.66B | YoY: +15.6% |
| #10 | WEST PHARMACEUTICAL SERVICES INCWST | $3.07B | YoY: +6.3% |
| #11 | GLOBUS MEDICAL INCGMED | $2.94B | YoY: +16.7% |
| #12 | ICU MEDICAL INC/DEICUI | $2.23B | YoY: -6.3% |
| #13 | INTEGRA LIFESCIENCES HOLDINGS CORPIART | $1.64B | YoY: +1.5% |
| #14 | MERIT MEDICAL SYSTEMS INCMMSI | $1.52B | YoY: +11.8% |
| #15 | Penumbra IncPEN | $1.40B | YoY: +17.5% |
| #16 | HAEMONETICS CORPHAE | $1.36B | YoY: +4.0% |
| #17 | Embecta Corp.EMBC | $1.08B | YoY: -3.8% |
| #18 | INSULET CORPPODD | $1.06B | YoY: +1.4% |
| #19 | TANDEM DIABETES CARE INCTNDM | $1.01B | YoY: +7.9% |
| #20 | Inspire Medical Systems, Inc.INSP | $912.0M | YoY: +13.6% |
| #21 | Orthofix Medical Inc.OFIX | $822.3M | YoY: +2.9% |
| #22 | Alphatec Holdings, Inc.ATEC | $764.2M | YoY: +25.0% |
| #23 | iRhythm Holdings, Inc.IRTC | $747.1M | YoY: +26.2% |
| #24 | NovoCure LtdNVCR | $655.4M | YoY: +8.3% |
| #25 | Bioventus Inc.BVS | $568.1M | YoY: -0.9% |
| Rank | Company | YoY Growth | Details |
|---|---|---|---|
| #1 | Orchestra BioMed Holdings, Inc.OBIO | +1169.2% | Revenue: $33.5M |
| #2 | DELCATH SYSTEMS, INC.DCTH | +129.1% | Revenue: $85.2M |
| #3 | KESTRA MEDICAL TECHNOLOGIES, LTD.KMTS | +115.1% | Revenue: $59.8M |
| #4 | SS Innovations International, Inc.SSII | +105.7% | Revenue: $42.5M |
| #5 | Neuronetics, Inc.STIM | +99.2% | Revenue: $149.2M |
| #6 | CARLSMED, INC.CARL | +85.9% | Revenue: $50.5M |
| #7 | SANUWAVE Health, Inc.SNWV | +67.9% | Revenue: $32.3M |
| #8 | Beta Bionics, Inc.BBNX | +53.9% | Revenue: $100.3M |
| #9 | TriSalus Life Sciences, Inc.TLSI | +53.4% | Revenue: $45.2M |
| #10 | SHOULDER INNOVATIONS, INC.SI | +49.6% | Revenue: $47.3M |
| #11 | UFP TECHNOLOGIES INCUFPT | +41.1% | Revenue: $148.1M |
| #12 | Heartflow, Inc.HTFL | +39.9% | Revenue: $176.0M |
| #13 | PROCEPT BioRobotics CorpPRCT | +37.2% | Revenue: $308.1M |
| #14 | NEPHROS INCNEPH | +32.7% | Revenue: $18.8M |
| #15 | GLAUKOS CorpGKOS | +32.3% | Revenue: $507.4M |
| #16 | KORU Medical Systems, Inc.KRMD | +30.3% | Revenue: $17.4M |
| #17 | LENSAR, Inc.LNSR | +28.7% | Revenue: $46.0M |
| #18 | Xtant Medical Holdings, Inc.XTNT | +28.4% | Revenue: $117.3M |
| #19 | iRhythm Holdings, Inc.IRTC | +26.2% | Revenue: $747.1M |
| #20 | NeuroPace IncNPCE | +25.1% | Revenue: $100.0M |
| #21 | Alphatec Holdings, Inc.ATEC | +25.0% | Revenue: $764.2M |
| #22 | PRO DEX INCPDEX | +23.7% | Revenue: $66.6M |
| #23 | SI-BONE, Inc.SIBN | +20.2% | Revenue: $200.9M |
| #24 | MIMEDX GROUP, INC.MDXG | +20.0% | Revenue: $418.6M |
| #25 | BOSTON SCIENTIFIC CORPBSX | +19.9% | Revenue: $20.07B |
| Rank | Company | Net Income | Details |
|---|---|---|---|
| #1 | 3M COMMM | $3.25B | Margin: 13.0% |
| #2 | BECTON DICKINSON & COBDX | $1.68B | Margin: 7.7% |
| #3 | Solventum CorpSOLV | $1.56B | Margin: 18.7% |
| #4 | RESMED INCRMD | $1.40B | Margin: 27.2% |
| #5 | Medline Inc.MDLN | $1.16B | Margin: 4.1% |
| #6 | DEXCOM INCDXCM | $836.3M | Margin: 17.9% |
| #7 | STRYKER CORPSYK | $654.0M | Margin: 11.1% |
| #8 | GLOBUS MEDICAL INCGMED | $537.9M | Margin: 18.3% |
| #9 | WEST PHARMACEUTICAL SERVICES INCWST | $493.7M | Margin: 16.1% |
| #10 | INSULET CORPPODD | $247.1M | Margin: 23.4% |
| #11 | Penumbra IncPEN | $177.7M | Margin: 12.7% |
| #12 | HAEMONETICS CORPHAE | $167.7M | Margin: 12.3% |
| #13 | Inspire Medical Systems, Inc.INSP | $145.4M | Margin: 15.9% |
| #14 | MERIT MEDICAL SYSTEMS INCMMSI | $128.5M | Margin: 8.5% |
| #15 | Embecta Corp.EMBC | $95.4M | Margin: 8.8% |
| #16 | TELEFLEX INCTFX | $95.0M | Margin: 22.9% |
| #17 | LEMAITRE VASCULAR INCLMAT | $57.7M | Margin: 23.1% |
| #18 | MIMEDX GROUP, INC.MDXG | $48.6M | Margin: 11.6% |
| #19 | Bioventus Inc.BVS | $22.7M | Margin: 4.0% |
| #20 | IRADIMED CORPIRMD | $22.5M | Margin: 26.8% |
| #21 | TACTILE SYSTEMS TECHNOLOGY INCTCMD | $19.1M | Margin: 5.8% |
| #22 | UFP TECHNOLOGIES INCUFPT | $17.2M | Margin: 11.6% |
| #23 | ARTIVION, INC.AORT | $9.8M | Margin: 2.2% |
| #24 | PRO DEX INCPDEX | $9.0M | Margin: 13.5% |
| #25 | InfuSystem Holdings, IncINFU | $6.6M | Margin: 62.8% |